Cargando…
Zuo Jin Wan Reverses the Resistance of Colorectal Cancer to Oxaliplatin by Regulating the MALAT1/miR-200s/JNK Signaling Pathway
BACKGROUND: Oxaliplatin (L-OHP) is a common chemotherapy drug used in the treatment of colorectal cancer (CRC). Our previous work showed that Zuo Jin Wan (ZJW), a traditional Chinese medicine prescription, could improve sensitivity to L-OHP in the treatment of CRC, but the detailed mechanism is not...
Autores principales: | Wei, Zhenzhen, Zhou, Jing, Yu, Hao, Pu, Yunzhou, Cheng, Yuelei, Zhang, Yi, Ji, Qing, Zhu, Huirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568309/ https://www.ncbi.nlm.nih.gov/pubmed/36248422 http://dx.doi.org/10.1155/2022/3032407 |
Ejemplares similares
-
Establishment of an Experimental Breast Cancer ZHENG Model and Curative Effect Evaluation of Zuo-Jin Wan
por: Du, Jia, et al.
Publicado: (2013) -
Zuo Jin Wan, a Traditional Chinese Herbal Formula, Reverses P-gp-Mediated MDR In Vitro and In Vivo
por: Sui, Hua, et al.
Publicado: (2013) -
Zuo Jin Wan Reverses DDP Resistance in Gastric Cancer through ROCK/PTEN/PI3K Signaling Pathway
por: Sun, Meng-Yao, et al.
Publicado: (2018) -
Synergistic Effect of Zuo Jin Wan on DDP-Induced Apoptosis in Human Gastric Cancer SGC-7901/DDP Cells
por: Tang, Qing-Feng, et al.
Publicado: (2014) -
The Zuo Jin Wan Formula Induces Mitochondrial Apoptosis of Cisplatin-Resistant Gastric Cancer Cells via Cofilin-1
por: Tang, Qing-Feng, et al.
Publicado: (2016)